Cong‐Yi Wang

12.4k total citations
231 papers, 8.1k citations indexed

About

Cong‐Yi Wang is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Cong‐Yi Wang has authored 231 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Molecular Biology, 57 papers in Immunology and 43 papers in Surgery. Recurrent topics in Cong‐Yi Wang's work include Immune Cell Function and Interaction (31 papers), Diabetes and associated disorders (23 papers) and Pancreatic function and diabetes (22 papers). Cong‐Yi Wang is often cited by papers focused on Immune Cell Function and Interaction (31 papers), Diabetes and associated disorders (23 papers) and Pancreatic function and diabetes (22 papers). Cong‐Yi Wang collaborates with scholars based in China, United States and Belgium. Cong‐Yi Wang's co-authors include Jin‐Xiong She, Zheng Dong, Ping Yang, Qilin Yu, Ping Yang, Weining Xiong, Man Jiang, Feili Gong, Yi Wang and Weikuan Gu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Physical Review Letters and Journal of Biological Chemistry.

In The Last Decade

Cong‐Yi Wang

227 papers receiving 8.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cong‐Yi Wang China 53 2.7k 1.6k 1.0k 904 891 231 8.1k
Ling Liu China 45 3.1k 1.1× 1.4k 0.9× 1.0k 1.0× 440 0.5× 589 0.7× 415 8.4k
Stuart A. Cook United Kingdom 53 4.8k 1.8× 859 0.5× 1.2k 1.1× 1.1k 1.2× 471 0.5× 208 11.3k
Yoshifusa Aizawa Japan 47 3.3k 1.2× 1.4k 0.9× 1.5k 1.4× 342 0.4× 899 1.0× 622 11.8k
Huey‐Kang Sytwu Taiwan 45 2.6k 1.0× 2.0k 1.3× 865 0.8× 737 0.8× 417 0.5× 198 6.6k
Michael Christiansen Denmark 57 4.0k 1.5× 979 0.6× 829 0.8× 634 0.7× 819 0.9× 354 11.3k
Kenichi Yoshida Japan 51 4.2k 1.5× 807 0.5× 767 0.8× 652 0.7× 618 0.7× 366 8.8k
Hongwei Wang China 44 3.1k 1.2× 1.5k 1.0× 625 0.6× 406 0.4× 463 0.5× 288 7.4k
Thomas Kislinger Canada 53 5.8k 2.1× 1.3k 0.8× 662 0.6× 519 0.6× 1.7k 1.9× 168 11.7k
Norbert Gretz Germany 54 6.1k 2.2× 1.1k 0.7× 960 0.9× 1.8k 2.0× 579 0.6× 246 11.8k
John Morser United States 49 3.6k 1.3× 1.9k 1.2× 616 0.6× 738 0.8× 961 1.1× 168 12.1k

Countries citing papers authored by Cong‐Yi Wang

Since Specialization
Citations

This map shows the geographic impact of Cong‐Yi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cong‐Yi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cong‐Yi Wang more than expected).

Fields of papers citing papers by Cong‐Yi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cong‐Yi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cong‐Yi Wang. The network helps show where Cong‐Yi Wang may publish in the future.

Co-authorship network of co-authors of Cong‐Yi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Cong‐Yi Wang. A scholar is included among the top collaborators of Cong‐Yi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cong‐Yi Wang. Cong‐Yi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Xiaqing, Huan Chen, Yushan Tian, et al.. (2025). Amelioration of obesity-associated disorders using solanesol with the mitigation of NLRP3 inflammasome activation and macrophage inflammation in adipose tissue. Food & Function. 16(5). 1903–1918. 4 indexed citations
2.
Tan, Xiaosheng, Zunsong Hu, Ding‐Sheng Jiang, et al.. (2025). Targeting Setdb1 in T cells induces transplant tolerance without compromising antitumor immunity. Nature Communications. 16(1). 4534–4534. 2 indexed citations
3.
Zhang, Leike, Qingxing Wang, Lingyu Zhang, et al.. (2023). CCR2 is a host entry receptor for severe fever with thrombocytopenia syndrome virus. Science Advances. 9(31). 33 indexed citations
4.
Zhang, Lei, Siyuan Wang, Guorao Wu, et al.. (2023). MBD2 facilitates tumor metastasis by mitigating DDB2 expression. Cell Death and Disease. 14(5). 303–303. 4 indexed citations
5.
Zhang, Jing, Longmin Chen, Qianqian Xu, et al.. (2023). Ubc9 regulates the expression of MHC II in dendritic cells to enhance DSS-induced colitis by mediating RBPJ SUMOylation. Cell Death and Disease. 14(11). 737–737. 2 indexed citations
6.
Yang, Chunliang, Fei Sun, Faxi Wang, et al.. (2022). The interferon regulatory factors, a double-edged sword, in the pathogenesis of type 1 diabetes. Cellular Immunology. 379. 104590–104590. 7 indexed citations
7.
Xie, Hao, Yuhan Wang, Xin Liu, et al.. (2022). SUMOylation of ERp44 enhances Ero1α ER retention contributing to the pathogenesis of obesity and insulin resistance. Metabolism. 139. 155351–155351. 14 indexed citations
8.
Wang, Faxi, Fei Sun, Ping Yang, et al.. (2022). The Essential Role of FoxO1 in the Regulation of Macrophage Function. BioMed Research International. 2022(1). 1068962–1068962. 15 indexed citations
9.
Yue, Tiantian, Fei Sun, Chunliang Yang, et al.. (2020). The AHR Signaling Attenuates Autoimmune Responses During the Development of Type 1 Diabetes. Frontiers in Immunology. 11. 1510–1510. 31 indexed citations
10.
Zhou, Mi, Ling Cheng, Xing Chen, et al.. (2018). MBD2 Ablation Impairs Lymphopoiesis and Impedes Progression and Maintenance of T-ALL. Cancer Research. 78(7). 1632–1642. 15 indexed citations
11.
Fu, Xiaoxia, Fei Sun, Faxi Wang, et al.. (2017). Aloperine Protects Mice against DSS-Induced Colitis by PP2A-Mediated PI3K/Akt/mTOR Signaling Suppression. Mediators of Inflammation. 2017. 1–14. 47 indexed citations
12.
Chen, Huilong, Xiang-Qin Xu, Sheng Cheng, et al.. (2016). CXCR4 inhibitor attenuates ovalbumin-induced airway inflammation and hyperresponsiveness by inhibiting Th17 and Tc17 cell immune response. Experimental and Therapeutic Medicine. 11(5). 1865–1870. 25 indexed citations
13.
Wang, Cong‐Yi, et al.. (2016). Microsatellite markers reveal genetic divergence among wild and cultured populations of Chinese sucker Myxocyprinus asiaticus. Genetics and Molecular Research. 15(2). 5 indexed citations
14.
Chen, Huilong, Sheng Cheng, Aili Wang, et al.. (2015). IL-21 does not involve in OVA-induced airway remodeling and chronic airway inflammation.. PubMed Central. 8(7). 10640–5. 7 indexed citations
15.
Zhang, Shu, Ping Yang, Qilin Yu, et al.. (2012). Loss of Dicer Exacerbates Cyclophosphamide-Induced Bladder Overactivity by Enhancing Purinergic Signaling. American Journal Of Pathology. 181(3). 937–946. 50 indexed citations
16.
Brooks, Craig R., Sung-Gyu Cho, Cong‐Yi Wang, Tianxin Yang, & Zheng Dong. (2010). Fragmented mitochondria are sensitized to Bax insertion and activation during apoptosis. American Journal of Physiology-Cell Physiology. 300(3). C447–C455. 126 indexed citations
17.
Duan, Lihua, Cong‐Yi Wang, Jie Chen, et al.. (2010). High-mobility group box 1 promotes early acute allograft rejection by enhancing IL-6-dependent Th17 alloreactive response. Laboratory Investigation. 91(1). 43–53. 62 indexed citations
18.
Zhou, Zheng, et al.. (2008). HMGB1 Regulates RANKL-Induced Osteoclastogenesis in a Manner Dependent on RAGE. Journal of Bone and Mineral Research. 23(7). 1084–1096. 128 indexed citations
19.
Dong, Guie, et al.. (2008). Induction of Apoptosis in Renal Tubular Cells by Histone Deacetylase Inhibitors, a Family of Anticancer Agents. Journal of Pharmacology and Experimental Therapeutics. 325(3). 978–984. 37 indexed citations
20.
Wang, Cong‐Yi, et al.. (1998). Characterization of mutations in patients with autoimmune polyglandular syndrome type 1 (APS1). Human Genetics. 103(6). 681–685. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ling Liu Breakdown of academic impact, for papers by Stuart A. Cook Breakdown of academic impact, for papers by Yoshifusa Aizawa Breakdown of academic impact, for papers by Huey‐Kang Sytwu Breakdown of academic impact, for papers by Michael Christiansen Breakdown of academic impact, for papers by Kenichi Yoshida Breakdown of academic impact, for papers by Hongwei Wang Breakdown of academic impact, for papers by Thomas Kislinger Breakdown of academic impact, for papers by Norbert Gretz Breakdown of academic impact, for papers by John Morser
Rankless by CCL
2026